Effects of the testosterone metabolite dihydrotestosterone and 5α-androstan-3α,17β-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts

Life Sciences

Volumn 73, Issue 12, 2003, Pages 1567-1575

  Petroni, A ^a   Blasevich, M ^a   Uziel, G ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Cholesterol ester; Peroxisomal oxidation; Testosterone metabolites; Very long chain fatty acids; X Adrenoleukodystrophy

Indexed keywords

ANDROSTANEDIOL; ANDROSTANOLONE; CHOLESTEROL ESTER; LIGNOCERIC ACID; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; DRUG EFFECT; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; OXIDATION; PEROXISOME; SCHOOL CHILD; SKIN FIBROBLAST;

EID: 0037627833     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00474-0     Document Type: Article

References (24)

1. Assies J., van Geel B., Barth P. Low dehydroepiandrosterone sulphate (DHEAS) levels in X-linked adrenoleukodystrophy. Clinical Endocrinology. 49:1998;691-693.
2. Celotti F., Melcangi R.C., Martini L. The 5α-reductase in the brain: molecular aspects and relation to brain function. Frontiers in Neuroendocrinology. 13:1992;163-215.
3. Dubois-Dalcq M., Feigenbaum V., Aubourg P. Neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends in Neurosciences. 22:1999;4-12.
4. Higgins C.F. ABC transporters: from microorganism to man. Annual Review of Cell Biology. 8:1992;67-113.
5. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry. 226:1957;131-139.
6. Grino P.B., Griffin J.E., Wilson J.D. Testosterone at high concentrations interacts with the human androgen receptor similar to dihydrotestosterone. Endocrinology. 126:1990;1165-1172.
7. Igarashi M., Schaumburg H.H., Powers J., Kishimoto Y., Kolodny E., Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. Journal of Neurochemistry. 26:1976;851-860.
8. Kemp S., Pujol A., Waterham H.R., van Geel B.M., Bohem C.D., Raymond G.V., Cutting R.G., Wanders R., Moser H.W. ABCD1 mutation and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Human Mutation. 18:2001;499-515.
9. Lazo O., Contreras M., Hashmi M., Stanley W., Irazu C., Singh I. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proceedings of the National Academy of Sciences of the United States of America. 85:1988;7647-7651.
10. Moser H.W. Dietary management of X-linked adrenoleukodystrophy. Annual Review of Nutrition. 15:1995;379-397.
11. Moser H.W. Adrenoleukodystrophy: phenotype, genetics, pathogenesis, and therapy. Brain. 120:1997;1485-1508.
12. Mosser J., Douar A.M., Sarde C.O., Feil R., Moser H., Poutska A.M., Mandel J.L., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 361:1993;726-730.
13. Ogino T., Schaumburg H.H., Suzuki K., Kishimoto Y., Moser A.E. Metabolic studies of adrenoleukodystrophy. Advances in Experimental Medicine and Biology. 100:1978;601-619.
14. O'Neill G.N., Aoki M., Brown R.H. ABCD1 translation-initiator mutation demonstrate genotype-phenotype correlation for AMN. Neurology. 57:2001;1956-1962.
15. Petroni A., Papini N., Blasevich M., Magnaghi V., Cavaretta I., Galli C., Melcangi R.C. Testosterone metabolites in patients reduce the levels of very long chain fatty acid accumulated in X-adrenoleukodystrophy fibroblasts. Neuroscience Letters. 289:2000;139-142.
16. Petroni A. Steroid and very long chain fatty acid metabolism in the neurodegenerative disease X-adrenoleukodystrophy. Current Topics in Neurochemistry. 2003;. (in press).
17. Powers J.M., Schaumburg H.H. The adrenal cortex in adrenoleukodystrophy. Archives of Pathology. 96:1973;151-153.
18. Powers J.M., Schaumburg H.H., Johnson A.B., Raine C.S. A correlative study of the adrenal cortex in adrenoleukodystrophy: evidence for a fatal intoxication with very long chain saturated fatty acids. Investigative Cell Pathology. 3:1980;353-376.
19. Powers J.M., Schaumburg H.H. The testis in adrenoleukodystrophy. American Journal of Pathology. 102:1981;90-98.
20. Reinecke C.J., Knoll D.P., Pretorius P.J., Steyn H.S., Simpson R.H.W. The correlation between biochemical and histopatological findings in adrenoleukodystrophy. Journal of Neurological Science. 70:1985;21-38.
21. 2. Analytical Biochemistry. 132:1983;400-404.
22. Singh I., Moser A., Moser H.W., Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts and amniocytes. Pediatric Research. 18:1984;286-290.
23. Singh I., Moser A.B., Goldfischer S., Moser H.W. Lignoceric acid is oxidized in the peroxisomes: implication for the Zelleweger cerebro-hepatorenal syndrome and adrenoleukodystrophy. Proceedings of the National Academy of Sciences of the United States of America. 81:1984;4203-4207.
24. Tsuji S., Ohno T., Miyatake T., Suzuki A., Yamakawa T. Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy. Journal of Biochemistry. 96:1984;1241-1247.